NCT03532139 2025-01-23
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Beth Israel Deaconess Medical Center
Phase 2 Completed
Clinical Trials
9 trialsNCT02706249 2021-07-08
Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00633061 2020-10-08
DVT
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT02366871 2020-03-31
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Phase 2 Completed
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT00426127 2017-12-29
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
University of Iowa
Phase 2 Terminated
NCT00908960 2017-12-19
MicroTEC
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01149304 2017-11-20
ELDORADO
University of Magdeburg
Phase 2 Completed
NCT00916669 2013-05-08
A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Massachusetts General Hospital
Phase 2 Withdrawn